Maryl Lambros

Company: Avista Therapeutics

Job title: Bioinformatics Scientist

Seminars:

Case Study: Advancing AAV Gene Therapy Vector Generation in Retina & CNS using ML-Guided scAAVengr-HUnT Platform 12:30 pm

• Leveraging our previous single cell-based scAAVengr pipeline, Avista created a new High, Unbiased Throughput (scAAVengr-HUnT) platform, modified to develop and test highly complex libraries of novel AAV variants • Avista’s Machine Learning (ML) model can design novel packaging-efficient libraries in unexplored sequence space • We utilize our ML-Guided scAAVengr-HUnT platform to rapidly engineer efficient…Read more

day: Day 2- translation 1